Basiliximab in the therapy of acute rejection after organ transplantation

被引：12

作者：

Chariat, MN

Erren, M

Chariat, M

Deng, M

Wolters, HH

Dietl, KH

机构：

[1] Univ Munster, Sch Med, Dept Surg, D-48149 Munster, Germany

[2] Univ Munster, Sch Med, Dept Clin Biochem, D-48149 Munster, Germany

[3] Univ Munster, Sch Med, Dept Cardiovasc Surg, D-48149 Munster, Germany

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 03期

关键词：

D O I：

10.1016/S0041-1345(01)02029-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2380 / 2380

页数：1

共 5 条

[1] PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL-ANTIBODY USED IN CADAVERIC RENAL-TRANSPLANTATION [J].

AMLOT, PL ;

RAWLINGS, E ;

FERNANDO, ON ;

GRIFFIN, PJ ;

HEINRICH, G ;

SCHREIER, MH ;

CASTAIGNE, JP ;

MOORE, R ;

SWENY, P .

TRANSPLANTATION, 1995, 60 (07) :748-756

[2] Predictive value of the CD45RO positive T-helper lymphocyte subset for acute cellular rejection during the early phase after kidney transplantation [J].

Erren, M ;

Arlt, M ;

Willeke, P ;

Schlüter, B ;

Junker, R ;

Deng, MC ;

Assmann, G ;

Dietl, HD ;

Senninger, N .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :319-321

[3]

Kovarik JM, 1996, TRANSPLANT P, V28, P913

[4] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[5] RESHAPING HUMAN-ANTIBODIES FOR THERAPY [J].

RIECHMANN, L ;

CLARK, M ;

WALDMANN, H ;

WINTER, G .

NATURE, 1988, 332 (6162) :323-327

← 1 →